| Literature DB >> 23082181 |
Qiang Xu1, Lee Zhang, Ting Li, Lan Zhang, Lin He, Ke Dong, Nannan Liu.
Abstract
Target site insensitivity resulting from point mutations within the voltage-gated sodium channel of the insect nervous system is known to be of primary importance in the development of resistance to pyrethroid insecticides. This study shifts current research paradigms by conducting, for the first time, a global analysis of all the naturally occurring mutations, both nonsynonymous and synonymous mutations, as well as mutation combinations in the entire mosquito sodium channel of Culex quinquefasciatus and analyzing their evolutionary and heritable feature and roles in insecticide resistance. Through a systematic analysis of comparing nucleotide polymorphisms in the entire sodium channel cDNAs of individuals between susceptible and resistant mosquito strains, between field parental mosquitoes and their permethrin selected offspring, and among different mosquito groups categorized by their levels of tolerance to specific permethrin concentrations within and among the mosquito strains of the field parental strains and their permethrin selected offspring, 3 nonsynonymous (A(109)S, L(982)F, and W(1573)R) and 6 synonymous (L(852), G(891), A(1241), D(1245), P(1249), and G(1733)) mutations were identified. The co-existence of all 9 mutations, both nonsynonymous and synonymous, and their homozygousity were found to be important factors for high levels of resistance. Our study, for the first time, provide a strong case demonstrating the co-existence of both nonsynonymous and synonymous mutations in the sodium channel of resistant mosquitoes in response to insecticide resistance and the inheritance of these mutations in the offspring of field mosquito strains following insecticide selection.Entities:
Mesh:
Substances:
Year: 2012 PMID: 23082181 PMCID: PMC3474719 DOI: 10.1371/journal.pone.0047609
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Permethrin treatment of Culex mosquitoes and mosquito groups generated after treatment.
| Permethrin Treatments | ||||||||||
| LC10 Treatment | LC50 Treatment | LC90 Treatment | ||||||||
| Strain | n |
| 1st Group | n |
| 2nd Groups | n |
| 3rd Groups | 4th Groups |
| PPM | (collect dead mosquitoes) | PPM | (collect dead mosquitoes) | PPM | (collect dead mosquitoes) | (collect alive mosquitoes) | ||||
| HAmCqG0 | ∼1500 | 0.005 | HAmCqG0-<LC10 | ∼1300 | 0.05 | HAmCqG0-LC10–50 | ∼700 | 0.2 | HAmCqG0-LC50–90 | HAmCqG0->LC90 |
| HAmCqG8 | ∼1500 | 2 | HAmCqG8-<LC10 | ∼1300 | 30 | HAmCqG8-LC10–50 | ∼700 | 60 | HAmCqG8-LC50–90 | HAmCqG8->LC90 |
Each treatment was repeated 3 times.
The total number of early 4th instar larvae used at the beginning of the permethrin treatment with LC10 for each replication.
The concentrations of permethrin to these mosquitoes have been identified previously [10], [18].
The mosquitoes surviving from permethrin treatment with LC10 10 h after treatment.
The mosquitoes surviving from the permethrin treatment with LC50 10 h after treatment.
Figure 1Graphic representation of the locations of synonymous and nonsynonymous mutations in the Cx. quinquefasciatus sodium channel.
The nonsynonymous mutations are indicated by solid dots and the locations are underlined. The synonymous mutations are indicated by open tetragons and the locations are in italics. Positions of the mutations are numbered according to amino acid sequences of Cx. quinquefasciatus (accession numbers: JN695777, JN695778, JN695779), the corresponding positions of which in house fly Vssc1 sodium channel protein are in parentheses. The domain locations of the mutations are assigned according to the sodium channel amino acid sequences in house flies [7], [37].
Non-synonymous and synonymous mutations in the Culex mosquito sodium channel.
| Mutation | Strain | n | Phenotype | Codons | ||
| A109S | S-Lab | 60 | Susceptible |
|
|
|
| S-LabG5 | 60 | 0.9-fold susceptibility |
|
|
| |
| HAmCqG0 | 60 | 10-fold resistance |
|
|
| |
| HAmCqG8 | 60 | 2,700-fold resistance |
|
|
| |
| L982F | S-Lab | 60 | Susceptible | TT | TT | TT |
| S-LabG5 | 60 | 0.9-fold susceptibility |
| TT | TT | |
| HAmCqG0 | 60 | 10-fold resistance | TT | TT | TT | |
| HAmCqG8 | 60 | 2,700-fold resistance | TT | TT | TT | |
| W1573R | S-Lab | 60 | Susceptible |
|
|
|
| S-LabG5 | 60 | 0.9-fold susceptibility |
|
|
| |
| HAmCqG0 | 60 | 10-fold resistance |
|
|
| |
| HAmCqG8 | 60 | 2,700-fold resistance |
|
|
| |
| L852L | S-Lab | 60 | Susceptible | CT | CT | CT |
| S-LabG5 | 60 | 0.9-fold susceptibility | CT | CT | CT | |
| HAmCqG0 | 60 | 10-fold resistance | CT | CT | CT | |
| HAmCqG8 | 60 | 2,700-fold resistance | CT | CT | CT | |
| G891G | S-Lab | 60 | Susceptible | GG | GG | GG |
| S-LabG5 | 60 | 0.9-fold susceptibility | GG | GG | GG | |
| HAmCqG0 | 60 | 10-fold resistance | GG | GG | GG | |
| HAmCqG8 | 60 | 2,700-fold resistance | GG | GG | GG | |
| A1241A | S-Lab | 60 | Susceptible | GC | GC | GC |
| S-LabG5 | 60 | 0.9-fold susceptibility | GC | GC | GC | |
| HAmCqG0 | 60 | 10-fold resistance | GC | GC | GC | |
| HAmCqG8 | 60 | 2,700-fold resistance | GC | GC | GC | |
| D1245D | S-Lab | 60 | Susceptible | GA | GA | GA |
| S-LabG5 | 60 | 0.9-fold susceptibility | GA | GA | GA | |
| HAmCqG0 | 60 | 10-fold resistance | GA | GA | GA | |
| HAmCqG8 | 60 | 2,700-fold resistance | GA | GA | GA | |
| P1249P | S-Lab | 60 | Susceptible | CC | CC | CC |
| S-LabG5 | 60 | 0.9-fold susceptibility | CC | CC | CC | |
| HAmCqG0 | 60 | 10-fold resistance | CC | CC | CC | |
| HAmCqG8 | 60 | 2,700-fold resistance | CC | CC | CC | |
| G1733G | S-Lab | 60 | Susceptible | GG | GG | GG |
| S-Lab | 60 | 0.9-fold susceptibility | GG | GG | GG | |
| HAmCqG0 | 60 | 10-fold resistance | GG | GG | GG | |
| HAmCqG8 | 60 | 2,700-fold resistance | GG | GG | GG | |
G0 represents the parental insects collected directly from the field; G8 represent the 8th generation of permethrin-selected HAmCqG0 offspring; Values represent mean ± SE for three replications of frequency (%) analyses of each mutation.
The total number of tested adult mosquitoes (three replicates for each of 20 [10 males and 10 females]).
Data from [18] except that for S-LabG5, which was tested in the current study (Table S2).
The nucleotide polymorphisms are underlined.
Non-synonymous mutations.
Synonymous mutations.
Co-occurrence of the kdr mutations in the HAmCq groups with difference levels of tolerance to permethrin.
| Polymorphisms at Amino Acid Mutation Sites | ||||||||||||
| A109S | L852L | G891G | L982F | A1241A | D1245D | P1249P | W1573R | G1733G | ||||
|
|
|
| G to T | G to A | C to A | A to T | A to G | C to T | G to A | T to C | A to G | |
| HAmCqG0 | 1 | 1 | 7.5 (3.5) | T | G | C | A | G | C | G | T | A/G |
| 2 | 42.5 (10) | T | G | C | A | G | C | G | T | G | ||
| 3 | 5 (0) | T | G | C | A | A/G | C/T | G/A | T | G | ||
| 4 | 32.5 (3.5) | T | G | C | A | G | C/T | G/A | T | G | ||
| 5 | 10 (0) | T | G/A | C/A | A/T | A/G | C/T | G/A | T | G | ||
| 11 | 2.5 (3.5) | T | G/A | C/A | A/T | G | T | A | T | G | ||
| 2 | 1 | 2.5 (3.5) | T | G | C | A | G | C | G | T | A/G | |
| 2 | 10 (7) | T | G | C | A | G | C | G | T | G | ||
| 4 | 27.5 (3.5) | T | G | C | A | G | C/T | G/A | T | G | ||
| 5 | 5 (0) | T | G/A | C/A | A/T | A/G | C/T | G/A | T | G | ||
| 8 | 32.5 (3.5) | T | G/A | C/A | A/T | G | C/T | G/A | T | G | ||
| 9 | 2.5 (3.5) | T | G/A | C/A | A/T | G | C/T | G/A | T/C | G | ||
| 11 | 12.5 (3.5) | T | G/A | C/A | A/T | G | T | A | T | G | ||
| 17 | 5 (0) | T | A | A | T | G | T | A | T | G | ||
| 19 | 2.5 (3.5) | T | A | A | T | G | T | A | T/C | G | ||
| 3 | 2 | 12.5 (3.5) | T | G | C | A | G | C | G | T | G | |
| 4 | 7.5 (3.5) | T | G | C | A | G | C/T | G/A | T | G | ||
| 5 | 2.5 (3.5) | T | G/A | C/A | A/T | A/G | C/T | G/A | T | G | ||
| 6 | 7.5 (3.5) | T | G | C | A | G | C/T | G/A | T/C | G | ||
| 8 | 47.5 (10.5) | T | G/A | C/A | A/T | G | C/T | G/A | T | G | ||
| 9 | 12.5 (3.5) | T | G/A | C/A | A/T | G | C/T | G/A | T/C | G | ||
| 12 | 2.5 (3.5) | T | G/A | A | T | G | T | G/A | T | G | ||
| 17 | 3.5 (3.5) | T | A | A | T | G | T | A | T | G | ||
| 19 | 5 (0) | T | A | A | T | G | T | A | T/C | G | ||
| 4 | 2 | 7.5 (3.5) | T | G | C | A | G | C | G | T | G | |
| 4 | 12.5 (3.5) | T | G | C | A | G | C/T | G/A | T | G | ||
| 5 | 5 (0) | T | G/A | C/A | A/T | A/G | C/T | G/A | T | G | ||
| 6 | 5 (0) | T | G | C | A | G | C/T | G/A | T/C | G | ||
| 8 | 27.5 (10.5) | T | G/A | C/A | A/T | G | C/T | G/A | T | G | ||
| 9 | 7.5 (3.5) | T | G/A | C/A | A/T | G | C/T | G/A | T/C | G | ||
| 11 | 7.5 (3.5) | T | G/A | C/A | A/T | G | T | A | T | G | ||
| 12 | 5 (0) | T | G/A | A | T | G | T | G/A | T | G | ||
| 17 | 7.5 (3.5) | T | A | A | T | G | T | A | T | G | ||
| 19 | 12.5 (3.5) | T | A | A | T | G | T | A | T/C | G | ||
| 20 | 2.5 (3.5) | T | A | A | T | G | T | A | C | G | ||
| HAmCqG10 | 1 | 7 | 2.5 (3.5) | T | G/A | C/A | T | A/G | C/T | G/A | T | G |
| 9 | 5 (0) | T | G/A | C/A | A/T | G | C/T | G/A | T/C | G | ||
| 10 | 17.5 (3.5) | T | G/A | C/A | T | A/G | C/T | G/A | T/C | G | ||
| 14 | 10 (0) | T | A | A | T | G | T | G | C | G | ||
| 15 | 7.5 (3.5) | T | A | A | T | G | T | G/A | T/C | G | ||
| 16 | 10 (7) | T | G/A | A | T | G | T | A | T/C | G | ||
| 19 | 35 (7) | T | A | A | T | G | T | A | T/C | G | ||
| 20 | 12.5 (3.5) | T | A | A | T | G | T | A | C | G | ||
| 2 | 7 | 10 (7) | T | G/A | C/A | T | A/G | C/T | G/A | T | G | |
| 10 | 12.5 (3.5) | T | G/A | C/A | T | A/G | C/T | G/A | T/C | G | ||
| 13 | 7.5 (3.5) | T | G/A | A | T | G | T | G/A | T/C | G | ||
| 14 | 2.5 (3.5) | T | A | A | T | G | T | G | C | G | ||
| 15 | 5 (0) | T | A | A | T | G | T | G/A | T/C | G | ||
| 18 | 7.5 (3.5) | T | G/A | A | T | G | T | A | C | G | ||
| 19 | 22.5 (10.5) | T | A | A | T | G | T | A | T/C | G | ||
| 20 | 32.5 (3.5) | T | A | A | T | G | T | A | C | G | ||
| 3 | 7 | 10 (7) | T | G/A | C/A | T | A/G | C/T | G/A | T | G | |
| 10 | 10 (0) | T | G/A | C/A | T | A/G | C/T | G/A | T/C | G | ||
| 15 | 10 (7) | T | A | A | T | G | T | G/A | T/C | G | ||
| 18 | 7.5 (3,5) | T | G/A | A | T | G | T | A | C | G | ||
| 19 | 22.5 (10.5) | T | A | A | T | G | T | A | T/C | G | ||
| 20 | 40 (7) | T | A | A | T | G | T | A | C | G | ||
| 4 | 7 | 12.5 (3.5) | T | G/A | C/A | T | A/G | C/T | G/A | T | G | |
| 10 | 10 (7) | T | G/A | C/A | T | A/G | C/T | G/A | T/C | G | ||
| 18 | 5 (0) | T | G/A | A | T | G | T | A | C | G | ||
| 19 | 10 (0) | T | A | A | T | G | T | A | T/C | G | ||
| 20 | 62.5 (10.5) | T | A | A | T | G | T | A | C | G | ||
Group 1 were mosquitoes with tolerance to the permethrin concentration
N: The numeral indicating each different combination of the mutations, which was designed by weighing the numbers of the homozygous susceptible alleles, heterozygous, and homozygous polymorphic alleles in the combination, i.e., the numeral was increased when the heterozygous and homozygous polymorphic alleles increased.
F: the frequency (%) of each of the mutation combinations occurred in each group. The total of 40 individuals (two replicates for each of 20 4th instar larvae) with all ten mutations in their sodium channel cDNAs was analyzed.
Figure 2Distribution of frequencies of allelic expression in mosquito groups threated with permethrin.
The frequency of allele expression shown along the Y axis is the percentage of the mosquitoes (n = 40) carrying the homozygous or heterozygous allele(s) of the mutation. Mosquito groups are shown along the X axis; 1, 2, 3, and 4 represent the groups in HAmCqG0 that are dead under LC10 concentration treatment, between LC10 and LC50, between LC50 and LC90 and alive above LC90, respectively; and 5, 6, 7, and 8 represent the groups in HAmCqG8 that are dead under LC10, between LC10 and LC50, between LC50 and LC90, and alive above LC90, respectively.
Pairwise Goeman's Bayesian score test values to check for correlation between SNP combination frequencies and permethrin resistance level.
| HAmCqG0 | HAmCqG8 | ||||||||
| Strain | Group | 1 | 2 | 3 | 4 | 1 | 2 | 3 | 4 |
| HAmCqG0 | 1 | – | |||||||
| 2 | 290 | – | |||||||
| 3 | 360 | 7.7 | – | ||||||
| 4 | 670 | 69 | 35 | – | |||||
| HAmCqG8 | 1 | 2400 | 1100 | 90 | 560 | – | |||
| 2 | 2500 | 1200 | 1000 | 650 | −7.5 | – | |||
| 3 | 2700 | 1300 | 1100 | 730 | 4.7 | −9.1 | – | ||
| 4 | 2800 | 1400 | 1200 | 770 | 30 | 3.7 | −6.1 | – | |
P<0.1;
P<0.05;
P<0.001.
Goeman’s Bayesian score test value based on 500 permutations. The Goeman’s Bayesian score represent a relative value of comparison of the paired samples. The higher the score values the more significant the correlation between resistance level and the SNP combination frequencies of paired samples.